Ivan Hyep, CFO of Bicara Therapeutics BCAX, has filed 0 purchases and 13 sales on the open market. Over the past 12 months that comes to a net sale of $2.1M. The latest trade was on 05/21.

IH

IH

Ivan Hyep

CFO

Company

Bicara Therapeutics BCAX

First filing

25/11/25

Trades

42 trades

Buys / sales

0 / 13

12-month net buying

−$2.1M

Last trade

05/21

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	05/21	05/26	9,200 sh	$20.42	$187,864	−6.0%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	04/21	04/22	9,200 sh	$23.00	$211,600	−6.0%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	03/23	03/24	9,200 sh	$18.52	$170,384	−6.0%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	03/03–03/04	03/05	16,518 sh2 trades	$18.23avg.	$301,046.85	−10.2%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	01/22	01/26	1,882 sh	$18.15	$34,158.3	−1.3%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	25/12/22	25/12/23	9,200 sh	$18.31	$168,452	−6.0%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	25/11/21–25/11/24	25/11/25	18,400 sh2 trades	$18.54avg.	$341,078	−11.2%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	25/10/09	25/10/10	6,415 sh	$18.23	$116,945.45	−4.2%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	25/10/06–25/10/08	25/10/08	30,385 sh3 trades	$18.21avg.	$553,232.73	−17.3%